Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury

Victoria L. DiBona, Mihir K. Shah, Kayla J. Krause, Wenxin Zhu, Mikayla M. Voglewede, Dana M. Smith, David P. Crockett, Huaye Zhang

Research output: Contribution to journalArticlepeer-review

Abstract

Within the brain, traumatic brain injury (TBI) alters synaptic plasticity and increases neuroinflammation and neuronal death. Yet, there lacks effective TBI treatments providing pleiotropic beneficial effects on these diverse cellular processes necessary for functional recovery. Here, we show the diabetes drug, metformin, significantly improves cognitive functions after controlled cortical impact (CCI) injury in mice, showing improved spatial learning and nest building. Furthermore, injured animals treated with metformin exhibit increased ramification of microglia processes, indicating reduced neuroinflammation. Finally, metformin treatment in vitro increased neuronal activation of partitioning defective 1 (Par1), a family of Ser/Thr kinases playing a key role in synaptic plasticity and neuroinflammation. These results suggest metformin is a promising therapeutic agent for targeting multiple cellular processes necessary for functional TBI recovery.

Original languageEnglish (US)
JournalNeuroscience Research
DOIs
StateAccepted/In press - 2021

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Keywords

  • Metformin
  • Microglia
  • Neuroinflammation
  • Par1/MARK
  • TBI

Fingerprint

Dive into the research topics of 'Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury'. Together they form a unique fingerprint.

Cite this